Statement Of Changes In Equity [Abstract]

Biofrontera AG - Filing #6464128

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	—	6,077 EUR	22,000 EUR	—	—	137,497 EUR	18,857 EUR	18,856 EUR	124,739 EUR	—	—	19,980 EUR	—	—	63,807 EUR	1,000 EUR	137,330 EUR	—	181,158 EUR	—	20,336 EUR	180,789 EUR	63,807 EUR	0 EUR	137,318 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	0 EUR	0 EUR	—	—	4,350 EUR	0 EUR	—	—	—	—	4,350 EUR	369,000 EUR	—	0 EUR	—	—	—	—	0 EUR	—	369,000 EUR	—	—	—	—	—
Other comprehensive income	0 EUR	21,000 EUR	—	—	21,000 EUR	0 EUR	—	—	—	—	0 EUR	1,000 EUR	—	1,000 EUR	0 EUR	—	—	—	0 EUR	—	0 EUR	—	—	—	—	—
Comprehensive income	0 EUR	21,000 EUR	—	—	4,329 EUR	0 EUR	—	—	—	—	4,350 EUR	368,000 EUR	—	1,000 EUR	0 EUR	—	—	—	0 EUR	—	369,000 EUR	—	—	—	—	—
Issue of equity	3,038 EUR	0 EUR	—	—	3,343 EUR	305,000 EUR	—	—	—	—	0 EUR	0 EUR	—	0 EUR	0 EUR	—	—	—	0 EUR	—	0 EUR	—	—	—	—	—
Increase (decrease) through treasury share transactions, equity	60,769 EUR	0 EUR	—	—	0 EUR	0 EUR	—	—	—	—	60,769 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	0 EUR	0 EUR	—	—	0 EUR	0 EUR	—	—	—	—	0 EUR	12,000 EUR	—	0 EUR	0 EUR	—	—	—	12,000 EUR	—	0 EUR	—	—	—	—	—